Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mismatch Repair01:20

Mismatch Repair

6.7K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.7K
Mismatch Repair01:36

Mismatch Repair

43.9K
Overview
43.9K
Mutations01:39

Mutations

94.7K
Overview
94.7K
Mutations01:35

Mutations

44.7K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.7K
Mutations in Microorganisms01:18

Mutations in Microorganisms

802
Mutations are heritable changes in an organism’s genome involving alterations in the base sequence of DNA or RNA. These changes can influence cellular processes and phenotypic traits, potentially transforming the unaltered wild type into a mutant form. Such changes, termed forward mutations, are pivotal in shaping the genetic diversity of organisms.RNA viruses exhibit the highest mutation rates due to the absence of robust proofreading mechanisms during genome replication. In contrast,...
802
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

4.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MEDUSA: Maintaining Entire DNA Duplexes for Utmost Sequencing Accuracy.

Clinical chemistry·2026
Same author

Clinical, Genetic, and Pathologic Variability in Myelodysplastic Syndromes and Precursor Conditions Across Race, Ethnicity, and Sex.

American journal of hematology·2026
Same author

Mutant SRSF2-associated impaired erythropoiesis is defined by increased mTORC1 signaling due to FYN missplicing.

Leukemia·2026
Same author

Exposure to Agent Orange and association with myelodysplastic syndromes.

Blood advances·2026
Same author

A novel approach to defining progression in MDS and precursor myeloid conditions in the MDS Natural History Study.

Blood advances·2026
Same author

CPX-351 selectively benefits patients with AML and myelodysplasia-related mutations in the pivotal randomized trial.

Blood advances·2026

Related Experiment Video

Updated: Feb 18, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

10.2K

Mutational complexity in myelodysplasia.

R Coleman Lindsley1

  • 1Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA.

Best Practice & Research. Clinical Haematology
|November 21, 2017
PubMed
Summary
This summary is machine-generated.

Myelodysplastic syndromes (MDS) involve diverse genetic mutations. This review explores how combined genetic events, environmental factors, and inherited conditions contribute to MDS pathogenesis and leukemia transformation.

Keywords:
GenesMDSMutationMyelodysplasiaMyelodysplastic syndromes

More Related Videos

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
11:06

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Published on: February 24, 2014

13.5K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.9K

Related Experiment Videos

Last Updated: Feb 18, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

10.2K
Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
11:06

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Published on: February 24, 2014

13.5K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.9K

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Background:

  • Myelodysplastic syndromes (MDS) exhibit significant genetic and clinical heterogeneity.
  • Mutations can drive clonal hematopoiesis with varying clinical consequences, including progression to acute myeloid leukemia.

Purpose of the Study:

  • To elucidate the pathogenesis of myelodysplastic syndromes (MDS).
  • To focus on the interplay of combinatorial genetic events, environmental factors, and inherited genetic conditions in MDS development.

Main Methods:

  • This review synthesizes current research on MDS pathogenesis.
  • It examines the contribution of genetic mutations, environmental exposures, and germline predispositions.

Main Results:

  • MDS pathogenesis is complex, arising from a combination of genetic alterations.
  • Environmental factors and inherited genetic conditions play crucial roles in disease initiation and progression.
  • Specific mutation patterns influence the risk of transformation to leukemia.

Conclusions:

  • Understanding the multifaceted origins of MDS is critical for developing targeted therapies.
  • Further research into combinatorial genetics, environmental impacts, and inherited factors will advance MDS treatment and prevention strategies.